montelukast

SAINT LAURENT, Quebec, July 25, 2023 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today announced the execution of a Research Grant Agreement…

Researchers at the IISc found that the drug binds strongly to one end ('C-terminal') of a SARS-CoV-2 protein called Nsp1, which is one of the first viral proteins unleashed inside human…

Fexofinadine is a very established anti-allergy drug with a market size of around 700 MT and expected to give immediate impetus to company’s export business.This approval of Fexofenadine is…